Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors
NCT01628887 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2013-07-16
Summary
This clinical trial studies a supportive education program for Latina breast cancer survivors. The Bilingual Breast Cancer Education Intervention (BBCEI) may help Latina breast cancer survivors know what to expect after completing breast cancer treatment and prepare them to cope with cancer related survivorship issues
Conditions
- Cancer Survivor
- Stage I Breast Cancer
- Stage II Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
Interventions
- OTHER
-
Educational Intervention
Undergo Bilingual Breast Cancer Educational Intervention
Sponsors & Collaborators
-
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Gloria Juarez, PhD · City of Hope Medical Center
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
NCT03198286 ·Status: COMPLETED ·Phase: NA
-
A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials
NCT07040891 ·Status: RECRUITING ·Phase: NA
-
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
NCT00014222 ·Status: COMPLETED ·Phase: PHASE3
-
Biology Guided Therapy for Breast Cancer for ER Positive
NCT04965688 ·Status: TERMINATED ·Phase: PHASE2
-
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
NCT02364557 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
NCT05262400 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
NCT02684032 ·Status: COMPLETED ·Phase: PHASE1
-
Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
NCT00897026 ·Status: COMPLETED
-
Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.
NCT00524303 ·Status: COMPLETED ·Phase: PHASE2
-
STOP Heart Disease in Breast Cancer Survivors Trial
NCT02674204 ·Status: TERMINATED ·Phase: PHASE2
-
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
NCT06983691 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer
NCT01471106 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients
NCT01625286 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
NCT03373708 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer
NCT02257775 ·Status: TERMINATED
-
Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
NCT00999804 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer
NCT00206453 ·Status: TERMINATED ·Phase: PHASE2
-
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery
NCT03624478 ·Status: COMPLETED ·Phase: PHASE2
-
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
NCT05901428 ·Status: RECRUITING ·Phase: PHASE3
-
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
NCT02003209 ·Status: COMPLETED ·Phase: PHASE3
-
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
NCT03628066 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
NCT06260033 ·Status: RECRUITING ·Phase: PHASE2
-
Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer
NCT07021846 ·Status: RECRUITING ·Phase: NA
-
Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
NCT00914043 ·Status: WITHDRAWN
-
Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741
NCT00991263 ·Status: COMPLETED